PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportshepatitis b
MeSH D006509 - hepatitis b
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D006525:Viral hepatitis human
0 Companies
0 Drugs
Success rate
D000086982:Blood-borne infections
0 Companies
0 Drugs
Success rate
D018347:Hepadnaviridae infections
0 Companies
0 Drugs
Success rate
D006509: 
Hepatitis b
41 Companies
17 Drugs
$
Success rate
D019694:Chronic hepatitis b
34 Companies
17 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaLamivudine, Abacavir Abacavir Lamivudine  2016-09-29   
Entecavir Entecavir  2014-08-26   
Lamivudine Lamivudine Teva  2009-10-23   
Lamivudine Lamivudine Teva Pharma B.V  2009-12-10   
Lamivudine, Zidovudine Lamivudine/Zidovudine Teva  2011-02-28   
MylanTenofovir disoproxil, Lamivudine Cimduo  2018-02-28   
Entecavir Entecavir Mylan  2017-09-18   
Lamivudine Lamivudine  2019-03-05   
Lamivudine, Zidovudine Lamivudine Zidovudine  2019-08-12   
Tenofovir disoproxil, Efavirenz, Lamivudine Symfi  2018-03-22   
Tenofovir disoproxil, Efavirenz, Lamivudine Symfi Lo  2018-02-05   
Lamivudine, Abacavir Abacavir Lamivudine  2023-12-22   
NATCO PharmaLamivudine Lamivudine  2016-03-04   
Lamivudine, Zidovudine Lamivudine Zidovudine  2014-08-28   
GSKLamivudine Epivir-hbv  1998-12-08   
Lamivudine Zeffix  1999-07-29   
CiplaLamivudine, Abacavir Abacavir Lamivudine  2017-03-28   
Entecavir Entecavir  2016-12-06   
Lamivudine Lamivudine  2017-03-03   
Lamivudine, Zidovudine Lamivudine Zidovudine  2018-09-07   
Chartwell PharmaceuticalsLamivudine, Abacavir Abacavir Lamivudine  2017-03-28   
Lamivudine, Zidovudine Lamivudine Zidovudine  2011-05-25   
Entecavir Entecavir  2017-05-11   
Tenofovir disoproxil, Lamivudine Temixys  2018-11-16   
Lamivudine Lamivudine  2014-10-31   
Lupin ResearchLamivudine, Abacavir, Zidovudine Abacavir Sulfate, Lamivudine Zidovudine  2013-12-05   
Lamivudine Lamivudine  2014-12-18   
Lamivudine, Zidovudine Lamivudine Zidovudine  2012-05-15   
NovartisTelbivudine Sebivo  2007-04-24   
Telbivudine Tyzeka 2023-09-11 2006-10-25   
Merck & CoDoravirine, Tenofovir disoproxil, Lamivudine Delstrigo 2032-08-30 2018-08-30 $249 M Y2024 
Raltegravir, Lamivudine Dutrebis 2022-10-21 2015-02-06   
Hepatitis b virus hbsag surface protein antigen HBVaxPro  2001-04-27   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
44%
11/25
Phase 2
72%
23/32
Phase 3
53%
20/38
Approved: 7Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Tenofovir disoproxil,
Efavirenz,
Lamivudine,
Abacavir,
Abacavir sulfate,
Zidovudine,
Tenofovir,
Fendrix
GSK
Lamivudine,
Benzocaine,
Antithrombin iii,
Alanine,
Edrecolomab,
Tenofovir,
Adefovir,
Carmellose,
Bepirovirsen,
Carboxymethylcellulose,
Sodium chloride,
Albinterferon alfa-2b,
Bevifimod,
Nadide,
Microcrystalline cellulose,
Edetic acid,
As03,
Synflorix,
Twinrix,
Fendrix,
Fluzone,
Prevenar13,
Prevnar13,
Menactra,
Pneumovax,
Gsk3965193,
Antacid,
Flumist,
Hepsera,
Flucelvax,
Prevenar,
Gsk3389404
Cipla
Lamivudine
Novartis
Telbivudine,
Antithrombin iii,
Tenofovir,
Doconexent,
Adefovir,
Albinterferon alfa-2b,
Aspartame,
Valine,
VALTORCITABINE,
Fendrix,
Arm1,
Hepsera,
Arm2
Sanofi
Lecithin,
Adefovir,
Bevifimod,
Recombivax,
Fendrix,
Prevenar13,
Prevnar13,
Pcv13,
Pneumovax,
Triapine,
Hepsera,
Prevenar
Merck & Co
Doravirine,
Raltegravir,
Tenofovir disoproxil,
Lamivudine,
Hepatitis b virus hbsag surface protein antigen,
Docusate,
Antithrombin iii,
Alanine,
Vicriviroc,
Tenofovir,
Alfacalcidol,
Adefovir,
Albinterferon alfa-2b,
Aspartame,
Bevifimod,
Corticorelin,
Recombivax,
Fendrix,
Fluzone,
Pneumovax,
Flumist,
Hepsera,
Flucelvax,
Prevenar,
Taxane
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use